Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 18c; Bumps Guidance Slightly

Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $1.82, $0.18 better than the analyst estimate of $1.64. Revenue for the quarter came in at $1.78 billion versus the consensus estimate of $1.72 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2022 EPS of $6.70-$6.90, versus prior of $6.65-$6.85 and the consensus of $6.72. Sees revenue -1% to +1%.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AXT appoints Tracy Liu to its board of directors
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM